Debriefing Consult for Psychiatric Symptoms After Severe Maternal Morbidity

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorCedars-Sinai Medical Center

About this trial

The primary objective of this study is to determine if a maternal fetal medicine (MFM) debriefing consult six to eight weeks postpartum reduces self-reported post-traumatic stress, depression, and anxiety symptoms following a delivery complicated by severe maternal morbidity (SMM). Individuals with a delivery complicated an intensive care unit (ICU) admission and/or blood product transfusion \>4 units will be included in this study. Participants will be randomized to an intervention or control group; all participants will complete patient questionnaires that screen for post-traumatic stress disorder, depression, and anxiety. Those in the control group will receive a virtual MFM debriefing consult at six weeks postpartum and those in the intervention group will have the option for a consult at twelve weeks postpartum, after the completion of the questionnaires.

Eligibility criteria

Qualifiers

None

Disqualifiers

Age <18 years

Non-English speakers

Any records flagged "break the glass" or "research opt out"

Trial design

Treatments tested in this trial

  • Virtual maternal fetal medicine debriefing consult

Treatment groups

52 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Cedars-Sinai Medical Center

Lead sponsor

Cedars Sinai Medical Center, Los Angeles, USA

Collaborator